Cactus Botanics launches low molecular weight HA

By staff reporter

- Last updated on GMT

UK-based Cactus Botanics has launched it low molecular weight
hyaluronic acid (HA), an ingredient finding more an more
applications in both the cosmetics and food industries.

Hyaluronic acid (HA) is a mucopolysacharide that exists naturally in all living organisms. In humans it is found in larger concentrations in the articular joints, eye fluid and, most abundantly, in the skin.

As the protein can hold up to 1000 times its own weigh in water it is known to play a vital part in the ageing process once levels are depleted in the skin. Maintaining levels of HA, whether it be through supplements, topical applications or injections, is said to reduce wrinkles caused by dehydration and general ageing.

Estee Lauder was the first to launch a mass market version of the treatment, which first featured as a rather expensive injection filler treatment in the US and was approved by the FDA in early 2004. Since then production of HA has expanded significantly and now, with supplies of cheaper HA coming on line from China, the potential for the ingredient is expanding significantly.

And now Cactus Botanics, with its Operations Centre in Shanghai, has announced it will be able to offer both high and low weight HA, primarily for the US and European markets.

Carol Cheow from Cactus Botanics told that the low molecular weight Hyaluronic acid requires an extra production step compared to normal Hyaluronic acid production and they use a chemical method to cut large molecular weight Hyaluronic Acid into low molecular weight, and that the company was currently able to produce at least 6 Mt annually.

"Our normal product is naturally fermented. However, we also can extract it from cockscomb. The only problem is that the product extracted from cockscomb is with much higher cost,"​ explained Cheow.

Anti-wrinkle products dominate the global dermal fillers market (86 per cent), according to a recent report from Medical Insight, Inc., which also put the total dermal fillers market at $441m (€340m) in 2005.

By 2011, the global market is predicted to grow by per cent to $1,473m (€1138m).

Related topics Formulation & Science Skin Care

Related news

Show more

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us


View more



Beauty 4.0 Podcast